NanoViricides Inc. (NNVC) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    NanoViricides Inc.

    AMEX: NNVC · Real-Time Price · USD
    1.39
    -0.04 (-2.80%)
    At close: Oct 03, 2025, 3:59 PM
    1.37
    -1.44%
    After-hours: Oct 03, 2025, 06:21 PM EDT

    NanoViricides Income Statement

    Financials in USD. Fiscal year is July - June.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Jun 30, 2025 Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
    Revenue
    		 n/a n/a n/a n/a n/a
    Cost of Revenue
    		 n/a 759.01K 747.53K 723.33K 704.54K
    Gross Profit
    		 n/a -759.01K -747.53K -723.33K -704.54K
    Operating Income
    		 -9,591.6B -8.52M -8.94M -8.11M -8.74M
    Interest Income
    		 124.83B 271.77K 355.83K 11.86K 9.35K
    Pretax Income
    		 -9,467B -8.29M -8.59M -8.11M -8.82M
    Net Income
    		 -9,467B -8.29M -8.59M -8.1M -8.82M
    Selling & General & Admin
    		 4,042.5B 3.08M 2.55M 2.33M 2.63M
    Research & Development
    		 5,549.1B 5.44M 6.39M 5.78M 6.11M
    Other Expenses
    		 n/a -759.01K n/a n/a n/a
    Operating Expenses
    		 9,591.6B 7.76M 8.94M 8.11M 8.74M
    Interest Expense
    		 -149M 49.81K 938.00 5.12K 85.41K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a
    Cost & Expenses
    		 n/a 8.52M 8.94M 8.11M 8.74M
    Income Tax Expense
    		 n/a n/a n/a -6.74K n/a
    Shares Outstanding (Basic)
    		 15.12M 11.87M 11.63M 11.53M 10.9M
    Shares Outstanding (Diluted)
    		 15.12M 11.87M 11.63M 11.53M 10.9M
    EPS (Basic)
    		 -0.63 -0.7 -0.74 -0.7 -0.81
    EPS (Diluted)
    		 -0.63 -0.7 -0.74 -0.7 -0.81
    EBITDA
    		 -9,591.6B -7.49M -7.84M -7.38M -8.03M
    EBIT
    		 n/a -8.24M -8.59M -8.1M -8.74M
    Depreciation & Amortization
    		 n/a 759.01K 747.53K 723.33K 704.54K

    Add to Watchlist